BlackRock Institutional Trust Company, N.A. - CASI PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$259,000
+3.6%
225,6500.0%0.00%
Q3 2016$250,000
-5.3%
225,6500.0%0.00%
Q2 2016$264,000
+10.5%
225,6500.0%0.00%
Q1 2016$239,000
+10.1%
225,6500.0%0.00%
Q4 2015$217,000
-10.0%
225,6500.0%0.00%
Q3 2015$241,000
-40.3%
225,6500.0%0.00%
Q2 2015$404,000
+21.3%
225,6500.0%0.00%
Q1 2015$333,000
+11.7%
225,650
+0.7%
0.00%
Q4 2014$298,000
-25.7%
224,1440.0%0.00%
Q3 2014$401,000224,1440.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Wellington Shields & Co., LLC 951,064$7,827,0004.06%
Wellington Shields Capital Management, LLC 855,056$7,037,0001.16%
Manatuck Hill Partners, LLC 15,090$124,0000.05%
Moors & Cabot, Inc. 22,935$187,0000.02%
Perceptive Advisors 43,682$360,0000.01%
ROYCE & ASSOCIATES LP 120,000$988,0000.01%
ALPS ADVISORS INC 125,015$1,029,0000.01%
MetLife Investment Management, LLC 26,316$217,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 136,518$1,124,0000.00%
Private Advisor Group, LLC 15,001$122,0000.00%
View complete list of CASI PHARMACEUTICALS INC shareholders